Report Detail
Global Transdermal Skin Patch Market Insights, Forecast to 2025
- RnM2420501 |
- 25 April, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
The global Transdermal Skin Patch market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Transdermal Skin Patch market based on company, product type, end user and key regions.
This report studies the global market size of Transdermal Skin Patch in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Transdermal Skin Patch in these regions.
This research report categorizes the global Transdermal Skin Patch market by top players/brands, region, type and end user. This report also studies the global Transdermal Skin Patch market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P.
Teva Pharmaceutical Industries Ltd.
Market size by Product
Fentanyl Transdermal Skin Patch
Nicotine Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Buprenorphine Transdermal Skin Patch
Market size by End User
Relieve Severe Pain
Stop Smoking Cigarettes
Treat An Overactive Bladder
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Transdermal Skin Patch market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Transdermal Skin Patch market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Transdermal Skin Patch companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Transdermal Skin Patch submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Transdermal Skin Patch are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Transdermal Skin Patch market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Transdermal Skin Patch Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Transdermal Skin Patch Market Size Growth Rate by Product
- 1.4.2 Fentanyl Transdermal Skin Patch
- 1.4.3 Nicotine Transdermal Skin Patch
- 1.4.4 Clonidine Transdermal Skin Patch
- 1.4.5 Buprenorphine Transdermal Skin Patch
- 1.5 Market by End User
- 1.5.1 Global Transdermal Skin Patch Market Size Growth Rate by End User
- 1.5.2 Relieve Severe Pain
- 1.5.3 Stop Smoking Cigarettes
- 1.5.4 Treat An Overactive Bladder
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Transdermal Skin Patch Market Size
- 2.1.1 Global Transdermal Skin Patch Revenue 2014-2025
- 2.1.2 Global Transdermal Skin Patch Sales 2014-2025
- 2.2 Transdermal Skin Patch Growth Rate by Regions
- 2.2.1 Global Transdermal Skin Patch Sales by Regions
- 2.2.2 Global Transdermal Skin Patch Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Transdermal Skin Patch Sales by Manufacturers
- 3.1.1 Transdermal Skin Patch Sales by Manufacturers
- 3.1.2 Transdermal Skin Patch Sales Market Share by Manufacturers
- 3.1.3 Global Transdermal Skin Patch Market Concentration Ratio (CR5 and HHI)
- 3.2 Transdermal Skin Patch Revenue by Manufacturers
- 3.2.1 Transdermal Skin Patch Revenue by Manufacturers (2014-2019)
- 3.2.2 Transdermal Skin Patch Revenue Share by Manufacturers (2014-2019)
- 3.3 Transdermal Skin Patch Price by Manufacturers
- 3.4 Transdermal Skin Patch Manufacturing Base Distribution, Product Types
- 3.4.1 Transdermal Skin Patch Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Transdermal Skin Patch Product Type
- 3.4.3 Date of International Manufacturers Enter into Transdermal Skin Patch Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Transdermal Skin Patch Sales by Product
- 4.2 Global Transdermal Skin Patch Revenue by Product
- 4.3 Transdermal Skin Patch Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Transdermal Skin Patch Breakdown Data by End User
6 North America
- 6.1 North America Transdermal Skin Patch by Countries
- 6.1.1 North America Transdermal Skin Patch Sales by Countries
- 6.1.2 North America Transdermal Skin Patch Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Transdermal Skin Patch by Product
- 6.3 North America Transdermal Skin Patch by End User
7 Europe
- 7.1 Europe Transdermal Skin Patch by Countries
- 7.1.1 Europe Transdermal Skin Patch Sales by Countries
- 7.1.2 Europe Transdermal Skin Patch Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Transdermal Skin Patch by Product
- 7.3 Europe Transdermal Skin Patch by End User
8 Asia Pacific
- 8.1 Asia Pacific Transdermal Skin Patch by Countries
- 8.1.1 Asia Pacific Transdermal Skin Patch Sales by Countries
- 8.1.2 Asia Pacific Transdermal Skin Patch Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Transdermal Skin Patch by Product
- 8.3 Asia Pacific Transdermal Skin Patch by End User
9 Central & South America
- 9.1 Central & South America Transdermal Skin Patch by Countries
- 9.1.1 Central & South America Transdermal Skin Patch Sales by Countries
- 9.1.2 Central & South America Transdermal Skin Patch Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Transdermal Skin Patch by Product
- 9.3 Central & South America Transdermal Skin Patch by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Transdermal Skin Patch by Countries
- 10.1.1 Middle East and Africa Transdermal Skin Patch Sales by Countries
- 10.1.2 Middle East and Africa Transdermal Skin Patch Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Transdermal Skin Patch by Product
- 10.3 Middle East and Africa Transdermal Skin Patch by End User
11 Company Profiles
- 11.1 Hisamitsu Pharmaceutical
- 11.1.1 Hisamitsu Pharmaceutical Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Products Offered
- 11.1.5 Hisamitsu Pharmaceutical Recent Development
- 11.2 Novartis
- 11.2.1 Novartis Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Novartis Transdermal Skin Patch Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Novartis Transdermal Skin Patch Products Offered
- 11.2.5 Novartis Recent Development
- 11.3 Johnson & Johnson
- 11.3.1 Johnson & Johnson Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Johnson & Johnson Transdermal Skin Patch Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Johnson & Johnson Transdermal Skin Patch Products Offered
- 11.3.5 Johnson & Johnson Recent Development
- 11.4 Teikoku Pharma
- 11.4.1 Teikoku Pharma Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Teikoku Pharma Transdermal Skin Patch Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Teikoku Pharma Transdermal Skin Patch Products Offered
- 11.4.5 Teikoku Pharma Recent Development
- 11.5 Mylan
- 11.5.1 Mylan Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Mylan Transdermal Skin Patch Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Mylan Transdermal Skin Patch Products Offered
- 11.5.5 Mylan Recent Development
- 11.6 Actavis
- 11.6.1 Actavis Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Actavis Transdermal Skin Patch Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Actavis Transdermal Skin Patch Products Offered
- 11.6.5 Actavis Recent Development
- 11.7 Mundipharma
- 11.7.1 Mundipharma Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Mundipharma Transdermal Skin Patch Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Mundipharma Transdermal Skin Patch Products Offered
- 11.7.5 Mundipharma Recent Development
- 11.8 Henan Lingrui Pharmaceutical
- 11.8.1 Henan Lingrui Pharmaceutical Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Products Offered
- 11.8.5 Henan Lingrui Pharmaceutical Recent Development
- 11.9 Changzhou Siyao
- 11.9.1 Changzhou Siyao Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Changzhou Siyao Transdermal Skin Patch Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Changzhou Siyao Transdermal Skin Patch Products Offered
- 11.9.5 Changzhou Siyao Recent Development
- 11.10 Rfl Pharmaceutical
- 11.10.1 Rfl Pharmaceutical Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Rfl Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Rfl Pharmaceutical Transdermal Skin Patch Products Offered
- 11.10.5 Rfl Pharmaceutical Recent Development
- 11.11 Luye Pharma Group Ltd.
- 11.12 Purdue Pharma L.P.
- 11.13 Teva Pharmaceutical Industries Ltd.
12 Future Forecast
- 12.1 Transdermal Skin Patch Market Forecast by Regions
- 12.1.1 Global Transdermal Skin Patch Sales Forecast by Regions 2019-2025
- 12.1.2 Global Transdermal Skin Patch Revenue Forecast by Regions 2019-2025
- 12.2 Transdermal Skin Patch Market Forecast by Product
- 12.2.1 Global Transdermal Skin Patch Sales Forecast by Product 2019-2025
- 12.2.2 Global Transdermal Skin Patch Revenue Forecast by Product 2019-2025
- 12.3 Transdermal Skin Patch Market Forecast by End User
- 12.4 North America Transdermal Skin Patch Forecast
- 12.5 Europe Transdermal Skin Patch Forecast
- 12.6 Asia Pacific Transdermal Skin Patch Forecast
- 12.7 Central & South America Transdermal Skin Patch Forecast
- 12.8 Middle East and Africa Transdermal Skin Patch Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Transdermal Skin Patch Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Transdermal Skin Patch . Industry analysis & Market Report on Transdermal Skin Patch is a syndicated market report, published as Global Transdermal Skin Patch Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Transdermal Skin Patch market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
